Jobs at Click Therapeutics
Click Therapeutics is a Boston-based digital therapeutics company that delivers prescription digital therapeutics for opioid use disorder and other substance use disorders. Their flagship product, Click, combines evidence‑based CBT and motivational interviewing with AI‑driven personalization, earning FDA clearance and partnering with leading pharma companies to scale impact.
Roles span software engineering, data science, product management, clinical research, regulatory affairs, quality assurance, and business development. Candidates can expect agile, cross‑functional teams focused on behavioral health outcomes, remote‑first or hybrid work options, and a culture that rewards measurable impact in patient care.
Job Transparency gives candidates direct access to Click Therapeutics’ salary ranges, employee sentiment, and interview insights, empowering you to benchmark offers, negotiate effectively, and gauge fit before you apply.
Senior/Principal Research Associate (Neuroscience)
Company: Voyager Therapeutics
Location: Cambridge
Posted Apr 04, 2023
Voyager Therapeutics is a biotechnology company focused on gene therapy and neurology, with a novel TRACER AAV capsid discovery platform for high target delivery and blood-brain barrier penetration. The company has alliances with Pfizer Inc., Novartis, and Neurocrine Biosciences, and a pipeline of preclinical programs in Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS).
Director Cheminformatics
Company: Matchpoint Therapeutics
Location: Boston, MA
Posted Apr 06, 2023
Matchpoint Therapeutics, a biotechnology company founded in 2021, is seeking a cheminformatician with extensive experience in drug discovery and cheminformatics. The ideal candidate will have a Ph.D. in a relevant field, 10+ years of experience, and a proven track record of innovation. They will partner with Matchpoint's leadership team to develop and execute a vision for state-of-the-art cheminformatic tools in covalent small molecule drug discovery. Key responsibilities include developing and deploying DL/ML models, analyzing in vitro and ADME properties, driving molecular design, and creating analysis and visualization tools.
SaMD Quality Intern
Company: Click Therapeutics
Location: New York City, NY
Posted Apr 02, 2023
Click Therapeutics is a company developing and commercializing software as prescription medical treatments for unmet medical needs. They have a broad pipeline of Digital Therapeutics across various therapeutic areas and are looking for an intern to support quality management systems and software development life cycle in a regulated environment.
Scientist 2/Sr. Scientist 1, Specificity Screening of Epigenome Editors
Company: Scribe Therapeutics
Location: East Bay
Posted Apr 05, 2023
Scientist 2/Sr. Scientist 1 is seeking a highly creative, passionate, and motivated individual to join Scribe Therapeutics as a Scientist on the Genotoxicity team. The role involves applying expertise in next-generation sequencing, epigenomics, and molecular biology to develop assays for detecting on- and off-target epigenome editing. The candidate should have hands-on experience with epigenomic assay development and a desire to build novel strategies for screening the specificity of Scribe's epigenome editing platform.
Senior Research Associate I/II, AAV Capsid Engineering (Capsid Discovery)
Company: Voyager Therapeutics
Location: Cambridge
Posted Apr 04, 2023
Voyager Therapeutics is a biotechnology company focused on gene therapy and neurology, with innovative expertise in capsid discovery and deep neuropharmacology capabilities. The company's TRACER AAV capsid discovery platform has generated novel capsids with high target delivery and blood-brain barrier penetration. Voyager's pipeline includes preclinical programs in Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS), each with validated targets and biomarkers. The company is seeking a Senior Research Associate I/II to support capsid programs aimed at improving tropism, tissue detargeting, and immune evasion.
Associate Director, Statistical Programming
Company: Corcept Therapeutics
Location: Peninsula
Posted Apr 03, 2023
Corcept is a commercial-stage company engaged in the discovery and development of drugs to treat severe endocrine, metabolic, oncologic and neurological disorders. The company has generated revenue of $402 million and net income of $101 million in 2022. It plans to initiate a Phase 2b trial in patients with non-alcoholic steatohepatitis (NASH) by the end of this year.
Senior Research Associate I/II, AAV Capsid Engineering
Company: Voyager Therapeutics
Location: Cambridge
Posted Apr 04, 2023
Voyager Therapeutics is a biotechnology company focused on gene therapy and neurology, with innovative expertise in capsid discovery and deep neuropharmacology. They have developed a TRACER AAV capsid discovery platform that generates novel capsids with high target delivery and blood-brain barrier penetration. The company is allied with Pfizer Inc., Novartis, and Neurocrine Biosciences, and has preclinical programs in Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). They are seeking a Senior Research Associate I/II to support capsid programs and bring novel capsids to the clinic.
Scientist/Senior Scientist
Company: Voyager Therapeutics
Location: Cambridge
Posted Apr 04, 2023
Voyager Therapeutics is a biotechnology company focused on gene therapy and neurology, with a platform that generates novel capsids for high target delivery and blood-brain barrier penetration. The company is seeking a Scientist/Senior Scientist to contribute to NHP studies for platform and discovery research.
Scientist I/II, Capsid Engineering (Capsid Discovery)
Company: Voyager Therapeutics
Location: Cambridge
Posted Apr 03, 2023
Voyager Therapeutics is a biotechnology company dedicated to breaking through barriers in gene therapy and neurology. They are leveraging innovative expertise in capsid discovery and deep neuropharmacology capabilities to address delivery challenges. Their TRACER AAV capsid discovery platform has generated novel capsids with high target delivery and blood-brain barrier penetration. Voyager is allied with Pfizer Inc., Novartis, and Neurocrine Biosciences, and has multiple programs in their pipeline, including preclinical programs in Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). They are looking for a Scientist I or II to support capsid programs aimed at improving tropism, tissue detargeting, and immune evasion.
Senior IT Applications Manager
Company: Corcept Therapeutics
Location: Peninsula
Posted Apr 05, 2023
Corcept is a commercial-stage company engaged in the discovery and development of drugs to treat severe endocrine, metabolic, oncologic and neurological disorders by modulating the effects of the hormone cortisol. The company has generated revenue of $402 million and net income of $101 million in 2022. They have discovered a portfolio of over 1,000 proprietary selective cortisol modulators, with lead compounds in Phase 2 and Phase 3 trials for various treatments. The company plans to initiate a Phase 2b trial in patients with non-alcoholic steatohepatitis (NASH) by the end of the year. They expect to submit several new drug applications in the next few years.
Scientist II/Sr. Scientist I, Specificity Screening of Epigenome Editors
Company: Scribe Therapeutics
Location: East Bay
Posted Apr 05, 2023
Scribe Therapeutics is seeking a highly creative, passionate, and motivated individual to join their Genotoxicity team as a Scientist. The role involves applying expertise in next-generation sequencing, epigenomics, and molecular biology to develop assays for detecting on- and off-target epigenome editing. The ideal candidate should have hands-on experience with epigenomic assay development and a desire to build novel strategies for screening the specificity of Scribe's epigenome editing platform.
Scientist I/II, Discovery-Muscle
Company: Scribe Therapeutics
Location: East Bay
Posted Apr 01, 2023
Scribe Therapeutics is a molecular engineering company focused on creating best-in-class in vivo therapies that permanently treat the underlying cause of disease. They are seeking a highly creative, passionate, and motivated individual to join their team in developing the next generation of CRISPR-based therapeutics. The candidate should have a passion for working collaboratively with biologists and bioengineers and deep knowledge of muscular dystrophies and upstream R&D processes for advanced therapeutic modalities in the muscle/neuromuscular space.